Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
Exp(B) | OR (95% CI) | p-value | Exp(B) | OR (95% CI) | p-value | |
Total population | ||||||
Age | 0.995 | 0.983–1.007 | 0.403 | |||
Male | 1.148 | 0.896–1.470 | 0.276 | |||
BMI | 0.995 | 0.956–1.036 | 0.808 | |||
Smoking | 0.951 | 0.730–1.237 | 0.706 | |||
Hypertension | 0.840 | 0.659–1.071 | 0.159 | |||
Diabetes mellitus | 0.812 | 0.608–1.085 | 0.159 | |||
Dyslipidemia | 1.184 | 0.930–1.509 | 0.171 | |||
CKD | 1.013 | 0.767–1.339 | 0.926 | |||
RAS inhibitor | 0.843 | 0.658–1.080 | 0.177 | 0.680 | 0.497–0.931 | 0.016 |
Beta-blocker | 1.340 | 0.991–1.811 | 0.057 | |||
CCB | 1.222 | 0.941–1.586 | 0.132 | |||
Statin | 1.131 | 0.885–1.445 | 0.325 | 1.477 | 1.084–2.014 | 0.014 |
SBP | 1.004 | 0.996–1.011 | 0.356 | |||
DBP | 0.977 | 0.965–0.988 | <0.001 | 0.951 | 0.935–0.967 | <0.001 |
PP | 1.023 | 1.013–1.034 | <0.001 | |||
cSBP | 0.999 | 0.993–1.006 | 0.876 | 1.021 | 1.008–1.033 | 0.001 |
baPWV | 1.001 | 1.000–1.001 | <0.001 | 1.075 | 1.021–1.133 | 0.006 |
ABI | 0.202 | 0.053–0.774 | 0.020 | 0.094 | 0.019–0.468 | 0.004 |
AIx@75 | 0.990 | 0.980–1.001 | 0.064 | 0.976 | 0.963–0.989 | <0.001 |
Patients without prior PCI history | ||||||
Age | 1.001 | 0.987–1.014 | 0.895 | |||
Male | 1.035 | 0.777–1.378 | 0.814 | |||
BMI | 0.980 | 0.935–1.027 | 0.390 | |||
Smoking | 1.021 | 0.749–1.393 | 0.894 | |||
Hypertension | 0.796 | 0.599–1.059 | 0.118 | 0.667 | 0.462–0.964 | 0.031 |
Diabetes mellitus | 0.950 | 0.658–1.371 | 0.783 | |||
Dyslipidemia | 1.176 | 0.864–1.602 | 0.303 | |||
CKD | 1.176 | 0.836–1.655 | 0.352 | |||
RAS inhibitor | 0.806 | 0.586–1.108 | 0.183 | |||
Beta-blocker | 1.305 | 0.839–2.029 | 0.237 | |||
CCB | 1.208 | 0.878–1.662 | 0.247 | 1.552 | 1.032–2.333 | 0.035 |
Statin | 1.100 | 0.790–1.532 | 0.573 | |||
SBP | 1.001 | 0.993–1.010 | 0.762 | |||
DBP | 0.974 | 0.961–0.987 | <0.001 | 0.952 | 0.933–0.971 | <0.001 |
PP | 1.022 | 1.010–1.034 | <0.001 | |||
cSBP | 0.998 | 0.990–1.005 | 0.528 | 1.016 | 1.001–1.030 | 0.034 |
baPWV | 1.001 | 1.000–1.001 | <0.001 | 1.106 | 1.039–1.177 | 0.002 |
ABI | 0.123 | 0.024–0.621 | 0.011 | 0.039 | 0.006–0.273 | 0.001 |
AIx@75 | 0.990 | 0.978–1.002 | 0.091 | 0.979 | 0.963–0.995 | 0.010 |
Patients with prior PCI history | ||||||
Age | 0.972 | 0.948–0.997 | 0.026 | |||
Male | 1.510 | 0.898–2.539 | 0.120 | |||
BMI | 1.038 | 0.959–1.123 | 0.355 | |||
Smoking | 0.792 | 0.480–1.307 | 0.361 | |||
Hypertension | 0.928 | 0.578–1.488 | 0.756 | |||
Diabetes mellitus | 0.575 | 0.352–0.937 | 0.027 | 0.556 | 0.318–0.970 | 0.039 |
Dyslipidemia | 1.113 | 0.581–2.132 | 0.747 | |||
CKD | 0.718 | 0.440–1.174 | 0.187 | |||
RAS inhibitor | 0.735 | 0.450–1.198 | 0.217 | |||
Beta-blocker | 1.340 | 0.842–2.132 | 0.217 | |||
CCB | 1.205 | 0.757–1.919 | 0.433 | |||
Statin | 1.066 | 0.559–2.033 | 0.847 | |||
SBP | 1.010 | 0.995–1.026 | 0.196 | |||
DBP | 0.983 | 0.961–1.006 | 0.142 | 0.953 | 0.923–0.984 | 0.003 |
PP | 1.029 | 1.008–1.049 | 0.005 | |||
cSBP | 1.005 | 0.992–1.018 | 0.465 | 1.032 | 1.010–1.054 | 0.004 |
baPWV | 1.000 | 1.000–1.001 | 0.256 | |||
ABI | 0.640 | 0.058–7.095 | 0.716 | |||
AIx@75 | 0.992 | 0.972–1.011 | 0.401 | 0.971 | 0.947–0.996 | 0.024 |